市場調査レポート

商品コード

1566213

経カテーテル塞栓および閉鎖デバイスの市場規模、シェア、成長分析、タイプ別、用途別、地域別 - 産業予測、2024年～2031年

Transcatheter Embolization and Occlusion Devices Market Size, Share, Growth Analysis, By Type (Coil, Non-Coil), By Application (Peripheral Vascular Disease, Oncology), By Region - Industry Forecast 2024-2031

出版日: 2024年10月02日 | 発行: SkyQuest

| ページ情報: 英文 157 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 800,088円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 935,952円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,071,816円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=150.96円

全表示
概要
目次

概要

サンプル依頼リストに入れる

経カテーテル塞栓および閉鎖デバイスの世界市場規模は、2022年に45億米ドルと評価され、2023年の48億2,000万米ドルから2031年には84億1,000万米ドルに成長し、予測期間中（2024-2031年）にCAGR 7.20％で成長する見通しです。

経カテーテル塞栓および閉鎖デバイスの世界市場は、異常な血管や組織への血流を阻害または減少させるための低侵襲ソリューションとしての有効性によって、最近著しい成長を遂げています。これらの重要な医療ツールは、腫瘍、動脈瘤、血管奇形などの様々な症状の治療に極めて重要です。高齢者は心血管疾患や様々ながんに罹患しやすいため、低侵襲治療法の必要性が高まっています。加えて、新興国全体のヘルスケア・インフラの進歩と相まって、ヘルスケア支出の急増が市場拡大をさらに後押ししています。こうした動向は、より安全で効率的な治療法を提供する革新的医療技術への着実なシフトを示しており、経カテーテル塞栓および閉鎖デバイスは現代ヘルスケアにおける重要な要素であると位置づけられています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Boston Scientific Corporation（US）
Terumo Corporation（Japan）
Medtronic（Ireland）
Abbott（US）
Cook Medical Inc.（US）
Penumbra, Inc.（US）
Johnson & Johnson（US）
Guerbet S.A.（France）
Merit Medical Systems, Inc.（US）
AngioDynamics, Inc.（US）
B. Braun Melsungen AG（Germany）
Humares（Germany）
Inari Medical, Inc.（US）
MicroVention, Inc.（US）
Endospan Ltd.（Israel）
Teleflex Incorporated（US）
Kaneka Corporation（Japan）
SentreHEART, Inc.（US）
Vascular Technologies（US）

Product Code: SQMIG35A2295

Global Transcatheter Embolization and Occlusion Devices Market size was valued at USD 4.5 billion in 2022 and is poised to grow from USD 4.82 billion in 2023 to USD 8.41 billion by 2031, growing at a CAGR of 7.20% during the forecast period (2024-2031).

The global market for transcatheter embolization and occlusion devices has witnessed remarkable growth recently, driven by their effectiveness as minimally invasive solutions for obstructing or diminishing blood flow to abnormal vessels or tissues. These essential medical tools are pivotal in treating a range of conditions such as tumors, aneurysms, and vascular malformations. A notable factor propelling market demand is the escalating geriatric population, as older adults are more susceptible to cardiovascular diseases and various cancers, thereby increasing the necessity for minimally invasive treatment modalities. Additionally, the surge in healthcare expenditure, coupled with advancements in healthcare infrastructure across emerging economies, is further bolstering market expansion. These trends indicate a steady shift toward innovative medical technologies that offer safer and more efficient treatment options, positioning transcatheter embolization and occlusion devices as a critical component in modern healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transcatheter Embolization and Occlusion Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transcatheter Embolization and Occlusion Devices Market Segmental Analysis

Global Transcatheter Embolization and Occlusion Devices Market is segmented by Type, Application, and region. Based on Type, the market is segmented into Coil, and Non-Coil. Based on Application, the market is segmented into Peripheral Vascular Disease, Oncology, Neurology, Urology, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Transcatheter Embolization and Occlusion Devices Market

The Global Transcatheter Embolization and Occlusion Devices market is significantly driven by the growing demand for minimally invasive treatment options. As healthcare continues to prioritize patient-centric care, both patients and medical professionals favor procedures that facilitate quicker recovery, shorter hospital stays, and a lowered likelihood of complications compared to traditional surgical approaches. This shift in preference not only reflects advancements in medical technology but also highlights the essential role of transcatheter embolization and occlusion devices in various therapeutic applications, thereby propelling market growth. Consequently, these devices are becoming integral to modern interventional radiology and vascular surgery practices.

Restraints in the Global Transcatheter Embolization and Occlusion Devices Market

The Global Transcatheter Embolization and Occlusion Devices market faces significant restraint due to the potential complications and adverse events associated with these procedures. Despite their efficacy, risks such as device migration, vessel perforation, thrombosis, or allergic reactions to embolic agents may deter both healthcare providers and patients from opting for such interventions. These concerns not only decrease patient confidence but also compel clinicians to reconsider the choice of these devices over alternative treatment options, ultimately hindering market growth. Increased scrutiny and regulatory hurdles, fueled by these risks, may further challenge the adoption and advancement of transcatheter technologies.

Market Trends of the Global Transcatheter Embolization and Occlusion Devices Market

The Global Transcatheter Embolization and Occlusion Devices market is witnessing significant growth, driven by the adoption of advanced technologies that enhance safety and efficacy. As the prevalence of chronic diseases rises, there is an increasing demand for minimally invasive procedures, further propelling market expansion. Additionally, favorable reimbursement policies are promoting greater utilization of these devices. Innovation is at the forefront, with emerging technologies continually improving treatment options and outcomes for various medical conditions. This confluence of factors positions the market for robust growth, as healthcare providers and patients increasingly recognize the benefits of transcatheter solutions.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Patent Analysis
Regulatory Landscape
Top Investment Analysis
Key Success Factor
Degree of Competition

Transcatheter Embolization and Occlusion Devices Market byType

Market Overview
Coil
- Pushable Coils
- Detachable Coils
Non-Coil
- Flow Diverting Devices
- Embolization Particles
- Liquid Embolics
- Others

Transcatheter Embolization and Occlusion Devices Market byApplication

Market Overview
Peripheral Vascular Disease
- Arterial Blockage
- Venous Blood clot
- Others
Oncology
Neurology
- Brain Aneurysm
- Cerebral Arteriovenous Malformations
- Others
Urology
- Benign Prostatic Hyperplasia/Urinary Retention
- Others
- Varicocele
Others

Transcatheter Embolization and Occlusion Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guerbet S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Humares (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inari Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVention, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endospan Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaneka Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SentreHEART, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vascular Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

経カテーテル塞栓および閉鎖デバイスの市場規模、シェア、成長分析、タイプ別、用途別、地域別 - 産業予測、2024年～2031年

Transcatheter Embolization and Occlusion Devices Market Size, Share, Growth Analysis, By Type (Coil, Non-Coil), By Application (Peripheral Vascular Disease, Oncology), By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

経カテーテル塞栓および閉鎖デバイス市場：タイプ別

経カテーテル塞栓および閉鎖デバイス市場：用途別

経カテーテル塞栓および閉鎖デバイス市場規模：地域別